Skip to main content

Risk Factors of Hospital Mortality after Re-laparotomy for Post-hepatectomy Hemorrhage

Abstract

Background

Post-hepatectomy hemorrhage (PHH) requiring re-laparotomy is a life-threatening situation and is associated with a considerably high hospital mortality rate. However, risk factors of hospital mortality in patients with this condition have not yet been investigated.

Methods

The perioperative data of 258 patients with hepatocellular carcinoma who underwent re-laparotomy for PHH from 1997 to 2011 were retrospectively reviewed and evaluated by univariate and multivariate analyses to identify risk factors of hospital mortality.

Result

Hospital death occurred in 43 patients between 16 h and 40 days after re-laparotomy, and the overall mortality rate was 16.7 %. The median time lag between first recognition of active bleeding and re-laparotomy was 6 h (range 0.5–34 h). The mortality of patients undergoing late re-laparotomy (≥6 h) was much higher than those undergoing early re-laparotomy (<6 h) (25 vs 8.6 %; P = 0.001). Multivariate analysis showed early time period (1997–2004) (P = 0.040), liver cirrhosis (P = 0.025), ineffective hemostasis during re-laparotomy due to coagulopathy (P = 0.038), late re-laparotomy (≥6 h) (P = 0.032), postoperative liver failure (P = 0.001), and postoperative acute renal failure requiring hemodialysis (P = 0.024) were independent risk factors of hospital mortality.

Conclusion

Immediate re-laparotomy is a key factor to reduce hospital mortality for patients with active bleeding after partial hepatectomy. More care should be taken in those patients who develop acute liver failure and/or serious acute renal failure after re-laparotomy.

This is a preview of subscription content, access via your institution.

References

  1. Asiyanbola B, Chang D, Gleisner AL et al (2008) Operative mortality after hepatic resection: are literature-based rates broadly applicable? J Gastrointest Surg 12:842–851

    PubMed  Article  Google Scholar 

  2. Belghiti J, Hiramatsu K, Benoist S et al (2000) Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 191:38–46

    PubMed  Article  CAS  Google Scholar 

  3. Jarnagin WR, Gonen M, Fong Y et al (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 236:397–406, discussion 406–407

    Google Scholar 

  4. Choti MA, Bowman HM, Pitt HA et al (1998) Should hepatic resections be performed at high-volume referral centers. J Gastrointest Surg 2:11–20

    PubMed  Article  CAS  Google Scholar 

  5. Taketomi A, Kitagawa D, Itoh S et al (2007) Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute’s experience with 625 patients. J Am Coll Surg 204:580–587

    PubMed  Article  Google Scholar 

  6. Capussotti L, Muratore A, Amisano M et al (2005) Liver resection for hepatocellular carcinoma on cirrhosis: analysis of mortality, morbidity and survival—a European single center experience. Eur J Surg Oncol 31:986–993

    PubMed  Article  CAS  Google Scholar 

  7. Nagasue N, Yukaya H, Kohno H et al (1988) Morbidity and mortality after major hepatic resection in cirrhotic patients with hepatocellular carcinoma. HPB Surg 1:45–56, discussion 56

    Google Scholar 

  8. Shimada M, Takenaka K, Fujiwara Y et al (1998) Risk factors linked to postoperative morbidity in patients with hepatocellular carcinoma. Br J Surg 85:195–198

    PubMed  Article  CAS  Google Scholar 

  9. Schroeder RA, Marroquin CE, Bute BP et al (2006) Predictive indices of morbidity and mortality after liver resection. Ann Surg 243:373–379

    PubMed  Article  Google Scholar 

  10. Rahbari NN, Garden OJ, Padbury R et al the International Study Group of Liver Surgery (ISGLS) (2011) Post-hepatectomy hemorrhage: a definition and grading by the international study group of liver surgery (ISGLS). HPB (Oxford) 13:528–535

    Article  Google Scholar 

  11. Tsao JI, Loftus JP, Nagorney DM et al (1994) Trends in morbidity and mortality of hepatic resection for malignancy. A matched comparative analysis. Ann Surg 220:199–205

    Article  CAS  Google Scholar 

  12. Reissfelder C, Rahbari NN, Koch M et al (2011) Postoperative course and clinical significance of biochemical blood tests following hepatic resection. Br J Surg 98:836–844

    PubMed  Article  CAS  Google Scholar 

  13. Belghiti J, Hiramatsu K, Benoist S et al (2000) Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 191:38–46

    PubMed  Article  CAS  Google Scholar 

  14. Finch MD, Crosbie JL, Currie E et al (1998) An 8-year experience of hepatic resection: indications and outcome. Br J Surg 85:315–319

    PubMed  Article  CAS  Google Scholar 

  15. Belghiti J, Di Carlo I, Sauvanet A et al (1994) A ten-year experience with hepatic resection in 338 patients: evolutions in indications and of operative mortality. Eur J Surg 160:277–282

    PubMed  CAS  Google Scholar 

  16. Sitzmann JV, Greene PS (1994) Perioperative predictors of morbidity following hepatic resection for neoplasm. A multivariate analysis of a single surgeon experience with 105 patients. Ann Surg 219:13–17

    PubMed  Article  CAS  Google Scholar 

  17. Yang T, Zhang J, Lu JH et al (2011) A new staging system for resectable hepatocellular carcinoma: comparison with six existing staging systems in a large Chinese cohort. J Cancer Res Clin Oncol 137:739–750

    PubMed  Article  Google Scholar 

  18. Shirabe K, Kajiyama K, Harimoto N et al (2010) Risk factors for massive bleeding during major hepatectomy. World J Surg 34:1555–1562. doi:10.1007/s00268-010-0495-3

    PubMed  Article  Google Scholar 

  19. Silva MA, Muralidharan V, Mirza DF (2004) The management of coagulopathy and blood loss in liver surgery. Semin Hematol 41:132–139

    PubMed  Article  Google Scholar 

  20. Ribero D, Curley SA, Imamura H et al (2008) Selection for resection of hepatocellular carcinoma and surgical strategy: indications for resection, evaluation of liver function, portal vein embolization, and resection. Ann Surg Oncol 15:986–992

    PubMed  Article  Google Scholar 

  21. Yang T, Lin C, Zhai J et al (2012) Surgical resection for advanced hepatocellular carcinoma according to Barcelona Clinic Liver Cancer (BCLC) staging. J Cancer Res Clin Oncol 138:1121–1129

    PubMed  Article  CAS  Google Scholar 

  22. Lau WY, Lai EC (2008) Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int 7:237–257

    PubMed  Google Scholar 

  23. Cauchy F, Fuks D, Belghiti J (2012) HCC: current surgical treatment concepts. Langenbecks Arch Surg 397:681–695

    PubMed  Article  CAS  Google Scholar 

  24. Bernstein DE, Jeffers L, Erhardtsen E et al (1997) Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: a preliminary study. Gastroenterology 113:1930–1937

    PubMed  Article  CAS  Google Scholar 

  25. Porte RJ, Leebeek FW (2002) Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery. Drugs 62:2193–2211

    PubMed  Article  CAS  Google Scholar 

  26. Lisman T, Leebeek FW, de Groot PG (2002) Haemostatic abnormalities in patients with liver disease. J Hepatol 37:280–287

    PubMed  Article  CAS  Google Scholar 

  27. Tripodi A (2008) Hemostasis abnormalities in liver cirrhosis: myth or reality. Pol Arch Med Wewn 118:445–448

    PubMed  Google Scholar 

  28. Heriot AG, Karanjia ND (2002) A review of techniques for liver resection. Ann R Coll Surg Engl 84:371–380

    PubMed  Article  CAS  Google Scholar 

  29. Richardson AJ, Laurence JM, Lam VW (2012) Portal triad clamping versus other methods of vascular control in liver resection: a systematic review and meta-analysis. HPB (Oxford) 14:355–364

    Article  Google Scholar 

  30. Lai EC, Lau WY (2005) The continuing challenge of hepatic cancer in Asia. Surgeon 3:210–215

    PubMed  Article  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by the National Natural Science Foundation of China (No. 81000166 and 81172020); Shanghai Program for Excellent Talents in Health System (No. XYQ2011033); Shanghai “Rising-Star” Science Foundation for Youths (No. 12QA1404800); and State Key Project on Infectious Diseases of China (2012ZX10002-016).

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Feng Shen or Jie-Wei Li.

Additional information

Tian Yang and Li Li contributed equally to this study.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Yang, T., Li, L., Zhong, Q. et al. Risk Factors of Hospital Mortality after Re-laparotomy for Post-hepatectomy Hemorrhage. World J Surg 37, 2394–2401 (2013). https://doi.org/10.1007/s00268-013-2147-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-013-2147-x

Keywords

  • Hospital Mortality
  • Partial Hepatectomy
  • Acute Liver Failure
  • Multiple Organ Dysfunction Syndrome
  • Pringle Maneuver